Efficacy and Safety of Daikenchuto for Constipation and Dose-Dependent Differences in Clinical Effects

Table 3

Clinical laboratory data of patients.

	Prior to DKT administration	Three days after DKT administration	One week after DKT administration	value
Na (mEq/L)	139 (136–141)	137 (134–140)	139 (137–140)	0.318
K (mEq/L)	4.2 (4.0–4.5)	4.2 (3.8–4.6)	4.4 (3.9–4.7)	0.0657
Cl (mEq/L)	102 (100–105)	101 (99–105)	102 (99–105)	0.123
AST (IU/L)	20 (18–24)	18 (13–28)	21 (16–27)	0.927
ALT (IU/L)	16 (12–23)	13 (11–23)	18 (11–25)	0.513
T-Bil (mg/dL)	0.6 (0.4–0.7)	0.5 (0.3–0.7)	0.5 (0.4–0.7)	0.284
BUN (mg/dL)	16 (14–21)	19 (15–26)	15 (10–24)	0.368
Cre (mg/dL)	0.82 (0.62–1.0)	0.7 (0.6–1.0)	0.7 (0.6–0.9)	0.744
Alb (g/dL)	3.4 (3.3–3.7)	3.2 (2.7–3.8)	3.2 (2.9–3.5)	0.135
BS (mg/dL)	112 (97–137)	101 (91–134)	105 (98–119)	0.607

AST, aspartate aminotransferase; ALT, alanine aminotransferase; T-Bil, total bilirubin; Cre, serum creatinine; BUN, blood urea nitrogen; Alb, albumin; BS, blood sugar; DKT, Daikenchuto.